PUBLISHER: Grand View Research | PRODUCT CODE: 1474856
PUBLISHER: Grand View Research | PRODUCT CODE: 1474856
The global regulatory information management system market size is anticipated to reach USD 4.12 billion by 2030 and is projected to grow at a CAGR of 10.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of centralized RIMS among the pharmaceutical and medical device industry along with technological advancements would likely drive the market growth over the forecast period.
The pharmaceutical sector's rapid expansion to meet global demand for innovative drugs increases regulatory complexity. To address this, companies are investing in RIM technology, leveraging automation and Artificial Intelligence (AI) to enhance regulatory workflows. Trends include outsourcing, reliance on business interaction, and the use of high-quality data for intelligent applications. For instance, in August 2022, Calyx's long-term client Krka expanded its investment in the Calyx RIM system for over 5 years, signalling a positive industry shift toward RIMS technology for effective regulatory compliance management.
The integration of advanced technologies offers a lucrative opportunity for market growth. Leveraging cutting-edge technologies, such as AI, ML, & predictive analytics, significantly bolsters risk assessment and mitigation strategies. These advanced tools enable the RIMS to rapidly analyze vast datasets, identifying patterns and potential risks that might go unnoticed through traditional methods.
Moreover, the automation capabilities of these technologies streamline processes, reducing the likelihood of human error and providing real-time insights into emerging risks. Integrating blockchain technology further enhances data security and transparency in risk management processes. For instance, IQVIA unveiled IQVIA RIM Smart, the industry's first fully integrated, comprehensive regulatory information management system which is cloud-based. Machine learning (ML) and artificial intelligence (AI) are being used more and more by businesses to enable intelligent management of a product portfolio's whole regulatory lifecycle.
Companies operating in the market are increasingly entering into strategic partnerships with RIMS solution providers to leverage their expertise & guidance in understanding global regulatory submission requirements. For example, in May 2023, LexisNexis Reed Tech, known for its analytic and data management solutions in the life sciences industry, expanded its collaboration with RegDesk, a well-known RIMS provider. Such ongoing strategic initiatives by market players are expected to fuel the adoption of RIMS.